Rheumatology Practice & Mycobacterial Diseases: Awareness, Screening, Treatment & Sequelae

Join Dr. Juzar Ali as he provides an update on identification, screening, and management of TB and non-tuberculosis mycobacteria (NTM) in non-HIV immune compromised patients seen specially in Rheumatology practices. Dr. Ali also discusses practical issues faced by physicians taking care of patients being treated with immune suppressive medications and biologic agents. (run time: presentation … Read more

Cell-mediated Immunity: Testing for SARS-CoV-2

Join Dr. Ruth Brignall as she reviews the immunology of SARS-CoV-2 infection and discusses how a cell-mediated immunity test could help to develop our understanding of immune responses to SARS-CoV-2 and provide additional insights into potential protective immunity against reinfection. (run time: presentation 37m35s, Q&A session 7m45s)

Diagnostic Update: Tuberculosis in Children

Join Ana M. Alvarez, MD as she presents an update on the diagnosis of latent Mycobacterium tuberculosis (TB) infection in children. Dr. Alvarez will review illustrative cases from pediatric patients, and she will discuss FAQs about TB infection in children. At the conclusion of this program, participants should be able to: Define latent TB infection¬†(LTBI) List the tests currently … Read more

Diagnosing TB in the Immunocompromised: What’s New?

Join Dr. Roy Chemaly as he discusses effective TB testing methods in the immunocompromised population. At the end of the presentation and discussion participants will be able to: Review current tuberculosis (TB) statistics Differentiate between the 3 TB testing methods Identify what constitutes immunocompromised patient populations Identify the clinical utility of interferon-gamma release assays (IGRAs) … Read more

LTBI Surveillance or TB Elimination? A More Rational Approach for US Healthcare Personnel

In recent years, the risk for tuberculosis exposure in healthcare settings has declined while both testing and treatment options have improved. This changing dynamic led to the development of updated guidelines: Tuberculosis Screening, Testing, and Treatment of U.S. Healthcare Personnel: Recommendations from the National Tuberculosis ControllersAssociation and CDC, 2019. Join us for a free webinar … Read more

Diagnosing Tuberculosis in the US: You Have a Vital Role!

As part of the End TB Strategy, healthcare providers in tuberculosis control have united with a goal of ending the global TB epidemic by 2035. Join Dr. Elizabeth Talbot as she discusses the importance of efficient TB and LTBI diagnosis, reviews new TB/LTBI diagnosis guidance and available testing methods, and shares diagnosis case experiences. (run … Read more

Leaving Oxford Immunotec Medical Education

You are now leaving the website of Oxford Immunotec Medical Education. External links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by Oxford Immunotec Medical Education of any of the products, services or opinions of the corporation or organization or individual. Oxford Immunotec Medical Education bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.
Contact the external site for answers to questions regarding its content.

Are you sure you want to visit ?

Yes No